Leukemia, Promyelocytic, Acute
"Leukemia, Promyelocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Descriptor ID |
D015473
|
| MeSH Number(s) |
C04.557.337.539.275.700
|
| Concept/Terms |
Leukemia, Promyelocytic, Acute- Leukemia, Promyelocytic, Acute
- Leukemia, Acute Promyelocytic
- Leukemia, Myeloid, Acute, M3
- M3 ANLL
- ANLL, M3
- Myeloid Leukemia, Acute, M3
- Progranulocytic Leukemia
- Promyelocytic Leukemia, Acute
- AML M3
- Acute Promyelocytic Leukemia
- Acute Promyelocytic Leukemias
- Leukemia, Progranulocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Promyelocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Promyelocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Promyelocytic, Acute" by people in this website by year, and whether "Leukemia, Promyelocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Promyelocytic, Acute" by people in Profiles.
-
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. Blood Adv. 2022 06 14; 6(11):3433-3439.
-
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance? Pediatr Blood Cancer. 2022 06; 69(6):e29613.
-
bcr3 PML-RARA: short fusion, small blasts! Blood. 2021 05 13; 137(19):2708.
-
Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry. Cytometry B Clin Cytom. 2021 07; 100(4):409-420.
-
Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) task force. J Geriatr Oncol. 2020 11; 11(8):1199-1209.
-
Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide. Am J Clin Pathol. 2019 10 07; 152(5):675-685.
-
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance). Pediatr Blood Cancer. 2019 03; 66(3):e27542.
-
Treatment of Acute Promyelocytic Leukemia in Adults. J Oncol Pract. 2018 11; 14(11):649-657.
-
A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017 Aug; 39(4):375-383.
-
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017 Mar 30; 129(13):1763-1767.